Trial
NCT03632317
A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Michigan Rogel Cancer Center
Collaborators
—
Condition
Glioma
Intervention
Panobinostat
Why stopped
low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-19